Terns Pharmaceuticals, Inc. (TERN) has 42 open-market insider trades by 14 insiders since 2021. The most active filer is Amy L. Burroughs, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Hongbo Lu | Dir | — | 4 | $23.0M | 2024-09-12 |
| Carl L. Gordon | Dir10% Owner | — | 4 | $19.1M | 2024-07-16 |
| James E. Flynn | 10% Owner | — | 1 | $11.3M | 2021-02-09 |
| Oriental Spring Venture Ltd | 10% Owner | — | 1 | $8.3M | 2022-11-23 |
| Vivo Capital Fund VIII, L.P. via Albert Cha | 10% Owner | — | 1 | $8.1M | 2021-02-09 |
| Amy L. Burroughs | CEO | — | 6 | $6.2M | 2026-03-16 |
| Vivo Capital Surplus Fund VIII, L.P. via Hongbo Lu | 10% Owner | — | 1 | $3.4M | 2022-08-15 |
| OrbiMed Genesis GP LLC | Dir10% Owner | — | 2 | $1.1M | 2024-07-16 |
| Emil Kuriakose | — | — | 6 | $133K | 2026-04-01 |
| Andrew Gengos | CFO | — | 2 | $77K | 2026-01-14 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Emil Kuriakose | — | Sell | $50K | 2026-04-01 |
| Amy L. Burroughs | CEO | Sell | $1.4M | 2026-03-16 |
| Amy L. Burroughs | CEO | Sell | $572K | 2026-02-17 |
| Amy L. Burroughs | CEO | Sell | $2.5M | 2026-01-15 |
| Amy L. Burroughs | CEO | Sell | $2.7M | 2026-01-05 |
| Emil Kuriakose | Chief Medical Officer | Sell | $45K | 2026-01-02 |
Companies that share insiders with TERN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Jill M. Quigley | Director | Sell | $441K | 2025-11-04 |
| Emil Kuriakose | Chief Medical Officer | Sell | $7K | 2025-10-01 |
| Emil Kuriakose | Chief Medical Officer | Sell | $4K | 2025-07-01 |
| Andrew Gengos | CFO | Buy | $20K | 2025-06-27 |
| Amy L. Burroughs | CEO | Buy | $180K | 2025-06-25 |
| Andrew Gengos | CFO | Buy | $57K | 2025-06-13 |
| Emil Kuriakose | Chief Medical Officer | Sell | $2K | 2025-04-01 |
| Mark J. Vignola | CFO | Sell | $152K | 2025-01-02 |
| Jill M. Quigley | Director | Sell | $137K | 2025-01-02 |